Maria Chaudhry, MBBS, a hematologist at The Ohio State University Comprehensive Cancer Center—James, discusses novel treatment regimens in relapsed/refractory multiple myeloma.
Maria Chaudhry, MBBS
Advertisement
Articles by Maria Chaudhry, MBBS
Maria Chaudhry, MBBS, discusses unmet needs in relapsed/refractory multiple myeloma.
Maria Chaudhry, MBBS, discusses the use of daratumumab (Darzalex), lenalidomide (Revlimid), and dexamethasone in transplant-ineligible patients with multiple myeloma.
Advertisement
Latest Updated Articles
Dr. Chaudhry on DRd Triplet in Transplant-Ineligible Multiple MyelomaPublished: January 7th 2020 | Updated:
Dr. Chaudhry on Unmet Needs in Relapsed/Refractory Multiple MyelomaPublished: January 9th 2020 | Updated:
Dr. Chaudhry on Novel Treatment Regimens in Relapsed/Refractory Multiple MyelomaPublished: January 16th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
4
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
5